CompletedNot Applicable

Safe Discharge in Lower Gastrointestinal Bleeding

Spain398 participantsStarted 2014-06-01

Plain-language summary

The increasing incidence in lower gastrointestinal bleeding (LGIB) leads to a rise in hospital admission. Many LGBI are self-limiting thus the several scores to identify low risk patients suited to outpatient care have been described. We aim to compare two of this scores (Oakland score and SHA2PE score) in terms of performace to predict "safe discharge" from the emergency department.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All \> 18 year old patients, male and women, admitted to our hospital between June 2014 and June 2019 because of LGIB (lower gastrointestinal bleeding). Exclusion Criteria: * Patients in whom LGIB occurred while already admitted for an other cause. * Patients with LGIB transferred from another hospital due to comorbidities or severity of the gastrointestinal bleeding episode. * Patients with post-polypectomy LGIB (endoscopic polypectomy \<14 days before admission). * Patients with gastrointestinal bleeding of unknown origin after a complete study. * Patients who had undergone digestive tract surgery in the previous month. * Patients with an ostomy. * Patients with known colorectal cancer who had not undergone surgery.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Safe Discharge

Timeframe: After 1 month of follow-up from the hospital discharge

Validation of SHA2PE score in our cohort

Timeframe: After 1 month of follow-up from the hospital discharge

Trial details

NCT IDNCT06409988

SponsorGermans Trias i Pujol Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-06-01

View on ClinicalTrials.gov More Lower GI Bleeding trials